Delivery Order SPE2DB20D1100-SPE2DB24FD3P2
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ZORYVE 0.3% FOAM 60GM medical products. The $2,415.63 firm fixed-price delivery order, which does not have a set-aside designation, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a comprehensive...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,076.60 firm fixed-price contract is for the supply of "ZORYVE 0.3% FOAM 60GM", a pharmaceutical product, with a performance period through July 9, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,556.21 firm fixed-price delivery order is for the supply of the medication "ZORYVE 0.3% FOAM 60GM." The award has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of ZORYVE 0.3% Foam, a pharmaceutical product, with a ceiling value of $3,707.10 and a period of performance ending on October 15, 2024. The contract is not set aside for any special business category. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award, valued at $2,988.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a topical medication, and does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.17, is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $6,172.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ZORYVE 0.3% cream, a pharmaceutical product, with a period of performance through June 26, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC1F6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,084.20 fixed-price delivery order is for the supply of 4568142799 ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract has a period of performance through May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation,...
This federal contract award is for the delivery of ZORYVE 0.3% foam, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed-price delivery order. The contract has a ceiling value of $1,215.56 and a completion date of May 29, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,983.94 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation,...